ICAM1 and ovarian carcinoma: Moreover, in a model for ovarian carcinoma and fibrosarcoma VLA-4-VCAM-1 as well as LFA-1-ICAM-1 interactions have been shown to mediate T cell infiltration in response to IL-12 treatment (92).